Myomo Appoints Mary-Katherine McClure as Chief Commercial OfficerBusiness Wire · Oct 12, 2026
Myomo to Present at the H.C. Wainwright 28th Annual Global Investment ConferenceBusiness Wire · Sep 1, 2026
Myomo Q2 Earnings Call HighlightsMarketBeat · Aug 9, 2026
Myomo, Inc. (MYO) Q2 2026 Earnings Call TranscriptSeeking Alpha · Aug 5, 2026
Myomo, Inc. (MYO) Reports Q2 Loss, Tops Revenue EstimatesZacks Investment Research · Aug 5, 2026
Myomo Reports Second Quarter 2026 Financial and Operating ResultsBusiness Wire · Aug 5, 2026Myomo, Inc. is a medical technology company specializing in wearable robotics. The company engineers and manufactures advanced myoelectric orthoses, primarily for individuals in the United States who experience neuromuscular impairments. Its flagship product, MyoPro, is an upper-limb brace that utilizes muscle signals to assist patients with weak or paralyzed arms, thereby enhancing their ability to perform daily activities.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 5, 2026 | -$0.10 | -$0.07 | Beat |
| May 7, 2026 | -$0.12 | -$0.09 | Beat |
| Mar 9, 2026 | -$0.09 | -$0.08 | Beat |
| Nov 10, 2025 | -$0.11 | -$0.09 | Beat |
| Aug 11, 2025 | -$0.11 | -$0.11 | Beat |
| May 7, 2025 | -$0.08 | -$0.08 | Beat |